Cardiovascular Drugs — Flashcards

Cardiovascular Drugs — Flashcards

Cardiovascular Drugs — Flashcards

On this page

172 flashcards— Page 3 of 18
#21

_____ is approved for use in homozygous familial hypercholesterolemia.

Hint: MTP inhibitor

#22

_____ is a selective bradykinin B2 receptor competitive antagonist.

#23

Nonspecific adverse effects of dihydropyridine CCBs include headache, _____, and flushing

#24

Hydralazine can cause hypotension, which may induce a reflex _____ that can worsen angina

#25

Cardiovascular (Cardiac Glycosides) _____ toxicity may cause blurry yellow vision, known as xanthopsia

#26

Vasospastic angina is relieved by _____ drugs, dihydropyridine Ca2+ channel blockers, and smoke cessation (if applicable)

#27

Prostacyclin analogs (epoprostenol/iloprost) can cause decreased platelet _____ and are potent vasodilators.

#28

_____ is an \u03b12 agonist that may be used to treat hypertensive urgency (limited situations).

#29

What is the mechanism of action of Vernakalant?_____ and voltage-dependent block of the early and late components of the sodium current.

#30

Class _____ antiarrhythmics treat arrhythmias by blocking sympathetic input to the SA and AV nodes

Want unlimited flashcards?

Get full access to all flashcards, spaced repetition, and progress tracking.

Start For Free
75% OFFLimited time offer
GET 75% OFF